JNJ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
JNJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Johnson & Johnson has the Profitability Rank of 9. It has a higher profitability and may stay that way.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:
1. Operating Margin %Johnson & Johnson's Operating Margin % for the quarter that ended in Sep. 2023 was 27.62%. As of today, Johnson & Johnson's Piotroski F-Score is 6.
For the Drug Manufacturers - General subindustry, Johnson & Johnson's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Profitability Rank distribution charts can be found below:
* The bar in red indicates where Johnson & Johnson's Profitability Rank falls into.
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.
Johnson & Johnson has the Profitability Rank of 9. It has a higher profitability and may stay that way.
Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.
Profitability Rank is based on these factors:
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Johnson & Johnson's Operating Margin % for the quarter that ended in Sep. 2023 is calculated as:
Operating Margin % | = | Operating Income (Q: Sep. 2023 ) | / | Revenue (Q: Sep. 2023 ) |
= | 5898 | / | 21351 | |
= | 27.62 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The zones of discrimination were as such:
Good or high score = 8 or 9
Bad or low score = 0 or 1
Johnson & Johnson has an F-score of 6 indicating the company's financial situation is typical for a stable company.
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank
Thank you for viewing the detailed overview of Johnson & Johnson's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
John C Reed | officer: EVP, Pharmaceuticals R&D | ONE JOHNSON & JOHNSON PLAZA, WHQ 2134, NEW BRUNSWICK NJ 08933 |
Paula A Johnson | director | 22 CHERRY HILL DRIVE, DANVERS MA 01923 |
James D. Swanson | officer: EVP, Chief Information Officer | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933 |
Elizabeth Forminard | officer: Executive VP, General Counsel | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933 |
Darius Adamczyk | director | 855 S. MINT STREET, CHARLOTTE NC 28202 |
William Hait | officer: See Remarks | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933 |
Vanessa Broadhurst | officer: EVP, Global Corp Aff. | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933 |
Mathai Mammen | officer: EVP, Pharm, R&D | THERAVANCE,INC., 901 GATEWAY BLVD., SOUTH SAN FRANCISCO CA 94080 |
Nadja West | director | 1915 REXFORD ROAD, CHARLOTTE NC 28211 |
Robert J Decker | officer: Controller, CAO | ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933 |
Hubert Joly | director | C/O BEST BUY CO, INC., 7601 PENN AVENUE SOUTH, RICHFIELD MN 55423 |
Mark A Weinberger | director | METLIFE, INC., 200 PARK AVENUE, NEW YORK NY 10166 |
Marillyn A Hewson | director | C/O CARPENTER TECHNOLOGY CORPORATION, PO BOX 14662, READING PA 19612-4662 |
Thibaut Mongon | officer: Exec VP, WW Chair, Consumer | JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933 |
Kathryn E Wengel | officer: EVP, Chief GSC Officer | JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933 |
From GuruFocus
By Business Wire 05-10-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.